Lung Cancers Recruiting Phase 2 Trials for Fruquintinib (DB11679)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03684967Study of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLCTreatment